MedPath
NMPA Approval

Gemcitabine Hydrochloride for Injection

国药准字H20249831

December 25, 2024

Drug Information

注射用盐酸吉西他滨

注射剂

0.2g(按C₉H₁₁F₂N₃O₄计)

化学药品

December 25, 2024

Company Information

Applicant Company

连云港经济技术开发区花果山大道567-11号楼5-6层

Manufacturing Company

连云港市振华路18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.